Nature has long proven to be a great source of novel antibiotics, and the European drug discovery and development company, Evotec AG, is linking up with a leading research institute in Germany, the Helmholtz Center for Infection Research (HZI), to develop cystobactamids, potentially a new class of antibiotics which are found in myxobacteria, or slime bacteria.
This is the latest collaboration by Evotec to feature a major center of academic excellence in infection research: the Hamburg,...